Kadmon will form a life sciences venture with Nano Terra

04/25/2011 | Xconomy · Genetic Engineering & Biotechnology News

Nano Terra and Kadmon Pharmaceuticals intend to create a joint venture, NT Life Sciences, to work on the former's Pharmacomer drug-discovery platform and three of its enzyme-targeting compounds. Kadmon will have exclusive global rights to the investigational drugs and the technology.

View Full Article in:

Xconomy · Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
Bridgewater, NJ